San Diego, CA, United States of America

Edward T Maggio

This inventor holds 53 USPTO granted patents and 37 published patent applications and 5 EPO patents, primarily in Drug Administration. Top assignees: Aegis Therapeutics, LLC, Neurelis, Inc., Synbiotics Corporation. Active years: 1983-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward T Maggio. Retrieved from https://idiyas.com/inventor/edward-t-maggio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 53 

% Patents Active = 90.6

 

Average Co-Inventor Count = 1.4

ph-index = 14

Forward Citations = 749(Granted Patents)

Forward Citations (Not Self Cited) = 533(Dec 10, 2025)


Company Filing History:


Years Active: 1983-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Intranasal Epinephrine
Benzodiazepine Compositions
Drug Administration
Absorption Enhancers
Pharmaceutical Composition
Controlled Release Formulations
Antibacterial Compositions
Alkylglycoside Compositions
Multimodal Particulate Formulations
Opioid Overdose Treatment
Active Agents
Stabilizing Compositions
53 patents (USPTO):Explore Patents

Title: Edward T Maggio: Innovator in Pharmaceutical Formulations

Introduction

Edward T Maggio, based in San Diego, CA, is a prolific inventor with an impressive portfolio of 48 patents. His work primarily focuses on pharmaceutical formulations, specifically those adapted for innovative delivery methods. Maggio's contributions to the field have significantly advanced treatment options for various medical conditions, particularly in emergency scenarios.

Latest Patents

Among his latest innovations, two noteworthy patents highlight Maggio's commitment to enhancing drug delivery. The first patent involves "Intranasal epinephrine formulations and methods for the treatment of disease," which provides drug products for nasal delivery that incorporate epinephrine. This formulation is particularly vital for treating anaphylaxis, offering rapid administration methods that could save lives. The second patent, "Administration of benzodiazepine compositions," involves pharmaceutical compositions designed for nasal administration. This invention aims to streamline the production and usage of benzodiazepine drugs, contributing to more effective treatment pathways.

Career Highlights

Edward T Maggio has had a notable career working with reputable companies in the biomedical field. He has contributed significantly to Aegis Therapeutics, LLC, and Synbiotics Corporation, where he applied his expertise to develop novel therapeutics and enhance drug delivery systems. His extensive experience in these organizations has helped shape the landscape of pharmaceutical innovations.

Collaborations

Throughout his career, Maggio has collaborated with esteemed colleagues including Steve Cartt and David Medeiros. Working alongside such talented professionals has undoubtedly enriched his work and expanded the impact of his inventions in the pharmaceutical industry.

Conclusion

Edward T Maggio's contributions to pharmaceutical formulations and drug delivery methods showcase his innovative spirit and dedication to improving healthcare outcomes. With numerous patents to his name and a solid collaborative network, he continues to be a driving force in the realm of medical advancements, particularly in treating critical conditions through effective drug delivery solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…